145 related articles for article (PubMed ID: 9282697)
1. Downs' syndrome with acute myeloid leukemia.
Tauro S
J Assoc Physicians India; 1995 Feb; 43(2):148. PubMed ID: 9282697
[No Abstract] [Full Text] [Related]
2. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
3. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
4. Origins of leukaemia in children with Down syndrome.
Hitzler JK; Zipursky A
Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome.
Klusmann JH; Reinhardt D; Hasle H; Kaspers GJ; Creutzig U; Hahlen K; van den Heuvel-Eibrink MM; Zwaan CM
Leukemia; 2007 Jul; 21(7):1584-7. PubMed ID: 17443226
[No Abstract] [Full Text] [Related]
6. [Acute megakaryoblastic leukemia in Down syndrome with 3 q-, dominated by tumor formation and myelofibrosis].
Hasegawa N; Hoshina H; Kudo H; Enomoto Y; Hayashi Y
Rinsho Ketsueki; 1988 Nov; 29(11):2079-85. PubMed ID: 2976850
[No Abstract] [Full Text] [Related]
7. [Congenital acute megakaryoblastic leukemia associated with trisomy 21].
Gomis F; Pérez Sirvent ML; Borrego D; Sempere A
Sangre (Barc); 1990 Dec; 35(6):485-6. PubMed ID: 2150895
[No Abstract] [Full Text] [Related]
8. Cytogenetic abnormalities associated with childhood acute myeloblastic leukemia.
Haas OA; Kronberger M; Mayerhofer L
Recent Results Cancer Res; 1993; 131():103-12. PubMed ID: 8210631
[No Abstract] [Full Text] [Related]
9. Down syndrome and GATA1-related transient leukemia.
Sandoval C; Pine SR
J Pediatr; 2007 Mar; 150(3):e34. PubMed ID: 17307526
[No Abstract] [Full Text] [Related]
10. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
11. Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome.
Doyle JJ; Thorner P; Poon A; Tanswell K; Kamel-Reid S; Zipursky A
Leuk Lymphoma; 1995 Apr; 17(3-4):345-50. PubMed ID: 8580807
[TBL] [Abstract][Full Text] [Related]
12. MTHFR 677C-->T and 1298A-->C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil.
Amorim MR; Zanrosso CW; Magalhães IQ; Pereira SC; Figueiredo A; Emerenciano M; Pinheiro VR; d'Andréa ML; Orioli IM; Koifman S; Pombo-de-Oliveira MS
Pediatr Hematol Oncol; 2008 Dec; 25(8):744-50. PubMed ID: 19065440
[TBL] [Abstract][Full Text] [Related]
13. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
14. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
15. High frequency of copy number alterations in myeloid leukaemia of Down syndrome.
Blink M; van den Heuvel-Eibrink MM; Aalbers AM; Balgobind BV; Hollink IH; Meijerink JP; van der Velden VH; Beverloo BH; de Haas V; Hasle H; Reinhardt D; Klusmann JH; Pieters R; Calado RT; Zwaan CM
Br J Haematol; 2012 Sep; 158(6):800-3. PubMed ID: 22775985
[No Abstract] [Full Text] [Related]
16. Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421.
O'Brien MM; Cao X; Pounds S; Dahl GV; Raimondi SC; Lacayo NJ; Taub J; Chang M; Weinstein HJ; Ravindranath Y; Inaba H; Campana D; Pui CH; Rubnitz JE
Leukemia; 2013 Mar; 27(3):731-4. PubMed ID: 22918081
[No Abstract] [Full Text] [Related]
17. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
18. [The molecular mechanism of leukemogenesis in Down syndrome-related acute megakaryocytic leukemia].
Ito E; Toki T
Nihon Rinsho; 2007 Jan; 65 Suppl 1():136-40. PubMed ID: 17476742
[No Abstract] [Full Text] [Related]
19. Transient leukemia in newborns with Down syndrome.
Massey GV
Pediatr Blood Cancer; 2005 Jan; 44(1):29-32. PubMed ID: 15558701
[TBL] [Abstract][Full Text] [Related]
20. Acute leukemias in children with Down syndrome.
Zwaan MC; Reinhardt D; Hitzler J; Vyas P
Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
